PulseAGGREGATOR

Home Feed Stories Sources Features

PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

Business Standard India

financeCenter

4h ago

Cipla partners with Qilu to license, supply Keytruda biosimilar in UStranslating…

Cipla's US subsidiary Invagen Pharmaceuticals will market Qilu Pharmaceutical's QL2107, a biosimilar to Merck's cancer drug Keytruda, in the United States

Factuality

70/100

Political Bias

Center

Ownership

Business Press Group

Country

India

Region

Asia

Language

Hindi

Keywords#Keytruda#Qilu#Cipla#biosimilar#finance

Read Original ↗ Article view

Comments

Loading comments…

Cipla partners with Qilu to license, supply Keytruda biosimilar in US | Pulse Aggregator